Clinical Trial Update: Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intraneural delivery of scAAV9/JeT-GAN into the vagus nerve for Giant Axonal Neuropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Axonal Neuropathy

Drugs mentioned

• scAAV9/JeT-GAN

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Giant Axonal Neuropathy (GAN) | Phase 1 | Status: RECRUITING